Tokyo, Japan

Daiichi Seiyaku Co., Ltd.


USPTO Granted Patents = 70

Forward Citations = 668

Loading Chart...
Loading Chart...

133 inventors (with patents filed for the assignee):

goldMedal Isao Hayakawa (12 out of 27 patents)

silverMedal Shohgo Atarashi (8 out of 12 patents)

bronzeMedal Shunzo Aibara (6 out of 6 patents)

4 Shinichiro Ashida (5 out of 7 patents)

5 Tosaku Miki (5 out of 6 patents)

6 Tamotsu Miwa (5 out of 5 patents)

7 Fumiyoshi Ishikawa (5 out of 5 patents)

8 Tetsuo Shiba (4 out of 14 patents)

9 Sadao Hirota (4 out of 7 patents)

10 Hidemasa Ogawa (4 out of 4 patents)

11 Masahide Asano (4 out of 6 patents)

12 Hiroshi Fujita (4 out of 7 patents)

13 Yasushi Abiko (4 out of 4 patents)

14 Yuichi Yamamura (4 out of 12 patents)

15 Hitoshi Yamauchi (3 out of 10 patents)


Core Competencies:
Gene Products
Pyridonecarboxylic Acid Derivatives
Baculovirus Vectors
Thrombocytopenia Treatment
Tissue Plasminogen Activator
Influenza Vaccine
Liposome Production
Antibacterial Agents
Cephalosporin Derivatives
Optical Resolution
Triazolopyrimidine Derivatives
Muramylpeptide Derivatives

70 patents:

Daiichi Seiyaku Co., Ltd. is a pharmaceutical company based in Japan. Established in 1942, it focuses on the research, development, manufacturing, and marketing of a wide range of pharmaceutical products. With a strong commitment to innovation, quality, and providing affordable healthcare solutions, Daiichi Seiyaku strives to improve the well-being and quality of life of people around the world.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

70 Patents

#584 in Tokyo

#1,377 in Japan

#10,345 in the World

...
Tokyo, Japan
Forward Citations = 668

133 inventors:

Please report any incorrect information to support@idiyas.com
Loading…